Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × acalabrutinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Mantle-Cell 14 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Lymphoma 3 Leukemia, B-Cell 3 Waldenstrom Macroglobulinemia 2 Lymphoproliferative Disorders 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphatic Diseases 2 Pyloric Stenosis, Hypertrophic 1 Neoplasms 1 Lymphoma, Follicular 1 Leukemia, Prolymphocytic 1 Heart Failure 1 Glioblastoma 1

Interventions

pembrolizumab 27 enfortumab vedotin 16 Nivolumab 14 Gemcitabine 12 avelumab 10 Magnetic Resonance Spectroscopy 10 Cisplatin 10 Carboplatin 10 Specimen Handling 9 sacituzumab govitecan 6 atezolizumab 6 durvalumab 5 Ipilimumab 5 Docetaxel 5 Paclitaxel 4 cabozantinib 3 Taxes 3 tislelizumab 2 relatlimab 2 lenvatinib 2 erdafitinib 2 Radiosurgery 2 Platinum 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Cryosurgery 2 CTLA-4 Antigen 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡